Scholars@Duke publication: Should we avoid heparin to eliminate HIT?

Should we avoid heparin to eliminate HIT?

Publication , Journal Article

Arepally, GM

Published in: Blood Adv

November 29, 2016

Published version (DOI) Link to item

Duke Scholars

Author Gowthami Morey Arepally Medicine, Hematology

Altmetric Attention Stats

Dimensions Citation Stats

Published In

Blood Adv

DOI

10.1182/bloodadvances.2016000083

ISSN

2473-9529

Publication Date

November 29, 2016

Volume

Issue

Start / End Page

Location

United States

Related Subject Headings

3201 Cardiovascular medicine and haematology

Citation

APA

Chicago

ICMJE

MLA

NLM

Arepally, G. M. (2016). Should we avoid heparin to eliminate HIT? Blood Adv, 1(1), 4. https://doi.org/10.1182/bloodadvances.2016000083

Arepally, Gowthami Morey. “Should we avoid heparin to eliminate HIT?” Blood Adv 1, no. 1 (November 29, 2016): 4. https://doi.org/10.1182/bloodadvances.2016000083.

Arepally GM. Should we avoid heparin to eliminate HIT? Blood Adv. 2016 Nov 29;1(1):4.

Arepally, Gowthami Morey. “Should we avoid heparin to eliminate HIT?” Blood Adv, vol. 1, no. 1, Nov. 2016, p. 4. Pubmed, doi:10.1182/bloodadvances.2016000083.

Arepally GM. Should we avoid heparin to eliminate HIT? Blood Adv. 2016 Nov 29;1(1):4.

Published In

Blood Adv

DOI

10.1182/bloodadvances.2016000083

ISSN

2473-9529

Publication Date

November 29, 2016

Volume

Issue

Start / End Page

Location

United States

Related Subject Headings

3201 Cardiovascular medicine and haematology